IN2014CN04155A - - Google Patents

Download PDF

Info

Publication number
IN2014CN04155A
IN2014CN04155A IN4155CHN2014A IN2014CN04155A IN 2014CN04155 A IN2014CN04155 A IN 2014CN04155A IN 4155CHN2014 A IN4155CHN2014 A IN 4155CHN2014A IN 2014CN04155 A IN2014CN04155 A IN 2014CN04155A
Authority
IN
India
Prior art keywords
aice
aices
actinoplanes
sequence
resembles
Prior art date
Application number
Other languages
English (en)
Inventor
Andreas Klein
Klaus Selber
Hermann Wehlmann
Winfried Rosen
Alfred Pühler
Patrick Schwientek
Jörn Kalinowski
Udo Wehmeier
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of IN2014CN04155A publication Critical patent/IN2014CN04155A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/365Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinoplanes (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN4155CHN2014 2011-12-08 2012-12-04 IN2014CN04155A (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11192618 2011-12-08
PCT/EP2012/074366 WO2013083566A1 (en) 2011-12-08 2012-12-04 New actinomycete integrative and conjugative element from actinoplanes sp. se50/110 as plasmid for genetic transformation of related actinobacteria

Publications (1)

Publication Number Publication Date
IN2014CN04155A true IN2014CN04155A (ro) 2015-07-17

Family

ID=47278320

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4155CHN2014 IN2014CN04155A (ro) 2011-12-08 2012-12-04

Country Status (12)

Country Link
US (2) US9217154B2 (ro)
EP (1) EP2788373B1 (ro)
JP (1) JP2015501641A (ro)
KR (1) KR20140109922A (ro)
CN (1) CN104144942A (ro)
AR (1) AR089117A1 (ro)
CA (1) CA2858259A1 (ro)
ES (1) ES2718331T3 (ro)
HK (1) HK1203970A1 (ro)
IL (1) IL232587A (ro)
IN (1) IN2014CN04155A (ro)
WO (1) WO2013083566A1 (ro)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2014CN04155A (ro) 2011-12-08 2015-07-17 Bayer Ip Gmbh
CN112592878B (zh) * 2020-12-25 2022-08-26 上海交通大学 增强正调控蛋白基因表达以提高阿卡波糖发酵水平的方法
CN112522174B (zh) * 2020-12-25 2022-08-09 上海交通大学 一种敲除负调控蛋白基因以提高阿卡波糖发酵水平的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
DE2209834C3 (de) 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
DE2347782C3 (de) 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4062950A (en) 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
KR20100034055A (ko) * 2007-07-27 2010-03-31 와이어쓰 엘엘씨 유전자 클러스터 또는 그의 일부를 클로닝하기 위한 벡터 및 방법
TW201217533A (en) * 2010-08-04 2012-05-01 Bayer Pharma AG Genomics of actinoplanes utahensis
IN2014CN04155A (ro) 2011-12-08 2015-07-17 Bayer Ip Gmbh

Also Published As

Publication number Publication date
CA2858259A1 (en) 2013-06-13
IL232587A0 (en) 2014-06-30
US20160130622A1 (en) 2016-05-12
CN104144942A (zh) 2014-11-12
US20140349346A1 (en) 2014-11-27
HK1203970A1 (en) 2015-11-06
US9562249B2 (en) 2017-02-07
IL232587A (en) 2017-08-31
JP2015501641A (ja) 2015-01-19
EP2788373A1 (en) 2014-10-15
EP2788373B1 (en) 2019-01-23
WO2013083566A1 (en) 2013-06-13
AR089117A1 (es) 2014-07-30
ES2718331T3 (es) 2019-07-01
US9217154B2 (en) 2015-12-22
KR20140109922A (ko) 2014-09-16

Similar Documents

Publication Publication Date Title
GB2569733A (en) RNA-guided nucleic acid modifying enzymes and methods of use thereof
MX2021000210A (es) Metodos y productos para transfeccion de celulas.
PH12019500421A1 (en) Distributed systems for the efficient production and use of microbe-based compositions
MX2019002498A (es) Metodos y productos para la expresion de proteinas en celulas.
EA201791417A1 (ru) Супрессия гена гентингтина, индуцированная рнк-интерференцией
MX2016016713A (es) Procesos y sistemas para el montaje de secuencias de acido nucleico.
MX2016007541A (es) Moléculas modificadas de ácido nucleico y usos de las mismas.
SG10201903381TA (en) Artificial nucleic acid molecules
MX2017004285A (es) Indicador biologico.
MX2014003979A (es) Nucleosidos, nucleotidos, y acidos nucleicos modificados, y usos de los mismos.
GB201020995D0 (en) Biological materials and uses thereof
PH12014501726A1 (en) Glyphosate resistant plants and associated methods
WO2015191911A3 (en) Protein enriched microvesicles and methods of making and using the same
MX2013003681A (es) Ácidos nucleicos manipulados y métodos de uso de los mismos.
WO2013181647A8 (en) Compositions and methods of producing isoprene and/or industrial bio-products using anaerobic microorganisms
MX2019007248A (es) Enzimas de polimerizacion para reacciones de secuenciacion.
PH12015500107A1 (en) Process for designing diverged, condon-optimized large repeated dna sequences
AU2017260426A1 (en) Engineered nucleases useful for treatment of hemophilia A
MX2018007325A (es) Promotor de catalasa modificado bidireccional de bacilo.
AR093330A1 (es) Metodo para la remocion de adn
MX2018005872A (es) Profarmacos de acido nucleico.
IN2014CN04155A (ro)
EA201790360A1 (ru) Получение полностью процессированного и функционального фактора x в фурин-секретирующей системе экспрессии млекопитающего
MY181148A (en) Microorganisms for producing diamine and process for producing diamine using them
MY178471A (en) Microorganisms for producing diamine and process for producing diamine using them